T20 blue caps

Throwing in some back ground info.

Data from the Surmount Trial of Zepbound

  • Nausea: Affects 24% to 37% of patients, making it the most frequent complaint.
  • Diarrhea: Affects 18% to 26% of users, often tied to changes in intestinal fluid absorption.
  • Constipation: Affects 16% to 24% of individuals due to slower intestinal transit times.
  • Vomiting: Occurs in 8% to 25% of patients, usually during initial weeks.
  • Abdominal Pain & Bloating: Experienced by 10% to 14% of patients.
Zepbound mimics GLP-1 and GIP hormones, which significantly delay gastric emptying. Because food moves slower and sits in the stomach longer, the physical environment of the gut alters rapidly. During the first 4 to 8 weeks, there are major changes to the gut microbiome (temporary dysbiosis.) This bacterial imbalance contributes heavily to sulfur burps, severe bloating, gas, and irregular bowel patterns.
 
Back
Top